Table 2. Quality assessment of included studies in the scoping review.

Reference	Abstract or summary	Randomization described	Blinding or concealment	Sample size calculation	N lost to follow up	Eligibility criteria given	Intervention described	Ethics approval	Baseline characteristics listed	Limits discussed	Quality and generalizability
Robertson et al. (2018) [15]	Yes	Yes	No	No	No	Yes	Well described	Yes	Yes	Yes	Moderate
Robertson et al. (2020) [16]	Yes	Yes	No	No	No	Yes	Well described	Yes	Yes	Yes	Moderate
Rogers et al. [13]	Yes	No	No	No	No	No	Briefly described	Not known	No	Yes	Poor; not generalizable
Spanager et al. [23]	Yes	N/A	N/A	No	No	Yes	Well described	Yes	Yes	Yes	Moderate
Cook et al. [22]	Yes	Yes	No	Yes	Yes	Yes	Briefly described	No	Yes	Yes, brief	Moderate; not generalizable
Weitz et al. [24]	Yes	Yes	No	No	No	Yes	Well described	Yes	Yes	Yes	Moderate
George et al. [14]	Yes	N/A	N/A	No	No	Yes	Well described	Not known	Yes, brief	No	Moderate
Noel at al. [11]	Yes	N/A	Yes	No	Yes	Yes	Briefly described	No	Yes, brief	No	Moderate
Holmboe et al. [10]	Yes	Yes (minimal)	Yes	No	Yes	Yes	Well described	Yes	Yes	Yes	High; generalizable
Newble et al. [21]	Yes	No	No	No	No	No	Moderately described	Not known	Yes, brief	No	Poor; not generalizable
Van der Vleuten et al. [17]	Yes	No	No	No	No	No	Moderately described	Not known	No	Yes	Poor; not generalizable
Ludbrook et al. [20]	Yes	No	No	No	No	Yes	Moderately described	Not known	Yes	Yes, brief	Poor; not generalizable
Dudek et al. 2013 [19]	Yes	No	Yes	Yes (not met)	Yes	Yes	Moderately described	Yes	No	Yes	Moderate generalizable
Dudek et al. 2012 [18]	Yes	No	Yes	No	No	Yes	Well described	Not known	Yes	Yes	Moderate generalizable